Abstract
The objective difficulties of managing patients with SARS-CoV-2 infection have attracted the attention of the global medical and scientific community. Despite the optimal treatment, in some cases a cascade of reactions is triggered. It leads to a deterioration in the clinical condition of patients, up to a fatal outcome. The article presents current research data on the pathogenesis, clinical and laboratory features of COVID-19 associated coagulopathy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
